Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: octreotide acetate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008NDANovartis Pharmaceuticals Corporation0078-0341-611 KIT in 1 KIT (0078-0341-61) * 5 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 SYRINGE * .75 mL in 1 PACKET
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008NDANovartis Pharmaceuticals Corporation0078-0342-611 KIT in 1 KIT (0078-0342-61) * .75 mL in 1 PACKET * 5 mL in 1 VIAL, SINGLE-USE * 2.5 mL in 1 SYRINGE
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008NDANovartis Pharmaceuticals Corporation0078-0646-811 VIAL, SINGLE-USE in 1 KIT (0078-0646-81) > 1 KIT in 1 VIAL, SINGLE-USE (0078-0646-61) * 6 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 SYRINGE
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008NDANovartis Pharmaceuticals Corporation0078-0647-811 VIAL, SINGLE-USE in 1 KIT (0078-0647-81) > 1 KIT in 1 VIAL, SINGLE-USE (0078-0647-61) * 6 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 SYRINGE
Novartis
SANDOSTATIN LAR
octreotide acetate
INJECTABLE;INJECTION021008NDANovartis Pharmaceuticals Corporation0078-0648-811 VIAL, SINGLE-USE in 1 KIT (0078-0648-81) > 1 KIT in 1 VIAL, SINGLE-USE (0078-0648-61) * 6 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 SYRINGE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot